What does CUSIP 04746L104 represent in this 13F holders report?

CUSIP 04746L104 is the security identifier for ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value used to aggregate holder disclosures.

How many institutions held ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value in Q3 2020?

54 institutional investors reported ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value for Q3 2020. Use the holders table for investor-level position and value details.

Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA)

CUSIP: 04746L104

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class: Equity / Common Stock, $0.0001 Par Value
Shares outstanding: 9,614,000
Total 13F shares: 21,658,200
Share change: +21,658,200
Total reported value: $395,426,446
Price per share: $18.46
Number of holders: 54
Value change: +$395,426,446
Number of buys: 54

Quarterly Holders Quick Answers

What is CUSIP 04746L104?
CUSIP 04746L104 identifies ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2020

Recent filing periods for CUSIP 04746L104:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q3 2020

As of 30 Sep 2020, Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) was held by 54 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,658,200 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, RTW INVESTMENTS, LP, VIKING GLOBAL INVESTORS LP, VR Adviser, LLC, Rock Springs Capital Management LP, CITADEL ADVISORS LLC, Avidity Partners Management LP, Logos Global Management LP, JANUS HENDERSON GROUP PLC, and BAKER BROS. ADVISORS LP. This page lists 54 institutional shareholders reporting positions in this security for the Q3 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2020 vs Q3 2025 Across Filers

Q3 2025 holders

Q3 2020 holders

Holder diff

Investor	Q3 2025 Shares	Q3 2020 Shares	Share Diff	Share Chg %	Q3 2025 Value $	Q3 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.